The publisher brings years of research experience to the 9th edition of this report. The 169-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Global Pour Point Depressants Market to Reach $1.9 Billion by 2027
Amid the COVID-19 crisis, the global market for Pour Point Depressants estimated at US$1.6 Billion in the year 2020, is projected to reach a revised size of US$1.9 Billion by 2027, growing at a CAGR of 2.3% over the period 2020-2027.
Lubricant Industry, one of the segments analyzed in the report, is projected to record 2% CAGR and reach US$1.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Oil & Gas Industry segment is readjusted to a revised 2.8% CAGR for the next 7-year period.
The U.S. Market is Estimated at $432.6 Million, While China is Forecast to Grow at 4.3% CAGR
The Pour Point Depressants market in the U.S. is estimated at US$432.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$368.1 Million by the year 2027 trailing a CAGR of 4.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.5% and 1.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1% CAGR.
Competitors identified in this market include, among others:
Afton Chemical Corporation
Akzo Nobel NV
Chevron Corporation
Clariant Chemicals (India) Ltd.
Croda International PLC
Evonik Industries AG
Innospec, Inc.
Sanyo Chemical Industries Ltd.
The Lubrizol Corporation
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Pour Point Depressants Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...
Banco Latinoamericano de Comercio Exterior, S.A. , a Panama-based multinational bank originally established by the central banks of 23 Latin-American and Caribbean countries to promote foreign trade and economic integration in the Region, announced...
Providing a comprehensive overview of NOVAGOLD's Environmental, Social and Governance (ESG) performance, emphasizing remarkable health and safety records, steadfast dedication to environmental protection, continuous community investment, extensive...
Dogness (International) Corporation ("Dogness" or the "Company") , a developer and manufacturer of a comprehensive line of Dogness-branded, OEM and private label pet products, today announced its financial results for the six months ended December...